Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias

被引:65
|
作者
Goizet, C
Lesca, G
Dürr, A
机构
[1] Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris 13, France
[2] Hop La Pitie Salpetriere, Dept Genet Cytogenet & Embryol, F-75651 Paris, France
[3] Hop Pellegrin Enfants, Serv Genet Med, Bordeaux, France
[4] Hop Hotel Dieu, Serv Genet, Lyon, France
关键词
D O I
10.1212/01.WNL.0000032255.75650.C2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To report a 7-year experience of presymptomatic testing in persons at risk for Huntington disease (HD) and to compare their characteristics and outcomes with those of persons at risk for a less disabling condition, autosomal dominant cerebellar ataxias (ADCA). Methods: The authors collected data on presymptomatic testing for HD (n = 712) and ADCA (n = 46) in 10 French centers. Results: The characteristics of applicants were similar in HD and ADCA, revealing a predominance of women, a low rate of completing the presymptomatic testing program, and a high rate of follow-up. The frequency of serious events was low (2% for HD, 5% for ADCA), but such events were also found after favorable results. Family planning was a more frequent reason for seeking presymptomatic testing in ADCA than in HD. Prenatal diagnosis was performed in only half of the pregnancies in HD carriers (n = 35) but in all of those in ADCA carriers (n = 4). Conclusion: Counseling in multistep and multidisciplinary teams is important not only for presymptomatic testing in HD but also for less disabling diseases.
引用
下载
收藏
页码:1330 / 1336
页数:7
相关论文
共 50 条
  • [21] Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review
    Rossi, Malco
    Perez-Lloret, Santiago
    Cerquetti, Daniel
    Merello, Marcelo
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (03): : 154 - 160
  • [22] Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias
    Stevanin, G
    Trottier, Y
    Cancel, G
    Durr, A
    David, G
    Didierjean, O
    Burk, K
    Imbert, G
    Saudou, F
    AbadaBendib, M
    GourfinkelAn, I
    Benomar, A
    Abbas, N
    Klockgether, T
    Grid, D
    Agid, Y
    Mandel, JL
    Brice, A
    HUMAN MOLECULAR GENETICS, 1996, 5 (12) : 1887 - 1892
  • [23] Features of autosomal dominant cerebellar ataxias with CAG repeat expansions
    Dürr, A
    Cancel, G
    Stevanin, G
    David, G
    Didierjean, O
    Brice, A
    NEUROLOGY, 1998, 50 (04) : A309 - A309
  • [24] SUICIDE AND PRESYMPTOMATIC TESTING IN HUNTINGTON DISEASE
    FARRER, LA
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1987, 26 (02): : 319 - 320
  • [25] PRESYMPTOMATIC TESTING FOR HUNTINGTON DISEASE - REPLY
    SHARPE, NF
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 49 (03): : 355 - 356
  • [26] Selection for presymptomatic testing for Huntington's disease: Who decides?
    Mansie, S
    Sheffield, L
    Forrest, S
    Chiu, E
    Lloyd, J
    JOURNAL OF MEDICAL GENETICS, 1996, 33 (12) : 1051 - 1052
  • [27] Autosomal dominant cerebellar ataxias: new genes and progress towards treatments
    Coarelli, Giulia
    Coutelier, Marie
    Durr, Alexandra
    LANCET NEUROLOGY, 2023, 22 (08): : 735 - 749
  • [28] Diagnostic and presymptomatic testing for Huntington's disease in the prison setting
    Huson, SM
    Hayden, F
    Blair, E
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [29] Selection for presymptomatic testing for Huntington's disease: Who decides?
    Binedell, J
    Soldan, JR
    Harper, PS
    JOURNAL OF MEDICAL GENETICS, 1996, 33 (02) : 173 - 174
  • [30] Polyneuropathy in autosomal dominant cerebellar ataxias:: Phenotype-genotype correlation
    Kubis, N
    Dürr, A
    Gugenheim, M
    Chneiweiss, H
    Mazzetti, P
    Brice, A
    Bouche, P
    MUSCLE & NERVE, 1999, 22 (06) : 712 - 717